Specific binding sites for corticosteroid-binding globulin were 
The steroid hormones cortisol and progesterone are secreted into the circulation by the adrenal cortex and ovary, respectively. They are not in simple solution in the plasma but rather are largely bound to the same trace protein, corticosteroidbinding globulin (CBG) (1) (2) (3) . The current model of steroid hormone action envisions that the free (i.e., non-proteinbound) steroids diffuse passively across the capillary and cell membranes to the cell's interior where they initiate hormone action (4) .
Over the years, evidence has appeared that indicates it might be necessary to modify this model. None of it, however, has been either sufficiently convincing or error-free to upset the free-hormone model. For instance, Rosner and Hochberg (5) provided biochemical evidence years ago that CBG-bound cortisol was as active, or possibly more active, than free cortisol in the induction of tyrosine aminotransferase activity in rat liver. Others provided biochemical evidence for the presence of CBG or a CBG-like binder in various glucocorticoid and progesterone target organs: pituitary (6, 7) , kidney (8) , uterus (9) (10) (11) , muscle (12) , lung (13) , breast cancer (14) , and lymphocytes (15) . A CBG-like molecule has also been identified in plasma-membrane fractions from liver (16) and pituitary cells (17) . Some of the biochemical demonstrations have been supported by the immunocytochemical visualization of intracellular CBG in liver (18) , uterus (2), kidney (2) , and lymphocytes (15) ; but some of these reports have been flawed by the omission of critical controls and/or a lack of evidence that the observations were not due to contamination with plasma (19) . More recently, however, in a well-controlled study, guinea pig CBG has been specifically localized immunohistochemically inside those pituitary cells (corticotrophs) which secrete corticotropin (20) .
All of the foregoing observations have appeared in a fragmented way, and no cohesive focus has forced their assembly into a meaningful physiological model. We felt that if they all were both correct and of physiological importance, then a membrane receptor for CBG should exist. The existence of such a receptor would provide both a specific mechanism whereby CBG could be internalized into cells via receptor-mediated endocytosis, and a center around which to bring together the aforementioned disparate observations. We therefore set out to determine whether there are specific cell membrane binding sites for CBG and found that CBG binds saturably and specifically to human prostatic membranes, as well as to membranes from other tissues. A preliminary report of some aspects of this study has been presented. § Results were the same whether membranes were prepared from fresh tissue or from tissue frozen for 2-4 weeks. Membranes (100,000 x g fraction) were also prepared from the kidneys, liver, spleen, and uterus of a single adult female rhesus monkey (Macaca mulatta) which, as part of a different protocol, had been treated with estradiol valerate (2 mg/day for 10 days). The rhesus monkey was anesthetized with sodium barbital, after which the desired organs were removed. Membranes were prepared as above. Membrane protein was determined by washing an aliquot of the membranes with 0.3 M sucrose and then treating it with 0.1 M NaOH at 70'C for 30 min. The membrane solution was then centrifuged at 16,000 x g and the protein content of the supernatant was ascertained (22) .
MATERIALS AND METHODS
CBG, containing 1 mol of cortisol per mol of CBG, was purified from pregnancy plasma by affinity and hydroxylapatite chromatography (23, 24) . Its purity was verified by polyacrylamide gel electrophoresis, both under nondenaturing conditions and in the presence of NaDodSO4, and by immunoelectrophoresis against antiserum to whole human 
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Proc. Natl. Acad. Sci. USA 83 (1986) serum. It was iodinated, using chloramine-T, to a specific activity of 0.1-0.3 mol of'251 per mol of CBG (24) . To be sure that the iodinated CBG was native, over 90% was shown to be specifically bound by a monospecific anti-CBG antiserum before using it in receptor binding experiments (data not shown). Human testosterone/estradiol-binding globulin (TEBG) and albumin were isolated as described (25) (26) (27) . Human transferrin was purchased from Sigma.
Binding took place in 1.5-ml Eppendorf polypropylene centrifuge tubes that were pretreated with 1.0 ml of buffer A for 1 hr at 370C to decrease test tube blanks. 125I-labeled CBG (125I-CBG, 250,000-300,000 cpm per tube, about 2 nM), plus or minus 14 Generally, about 2% of the added 125I-CBG was specifically bound. There were no statistically significant differences in binding between membranes prepared from prostates obtained by either transurethral or open prostatectomy.
RESULTS
The dependence of the binding of 125I-CBG to human prostatic membranes as a function of time and temperature is shown in Fig. 1 . The inset, which shows only specific binding, 5] . indicates that there was minimal binding at 4°C or at 23°C.
Binding increased with time at 37°C and began to plateau at 6 hr, which was chosen as the incubation time for subsequent experiments. These data are shown again in the main figure, where total and nonspecific binding are also indicated. Fig. 2 is a representative Scatchard analysis (28) of the specific binding of CBG to prostatic membranes at 37°C. The data are fit best by a straight line and indicate that CBG is bound to a single set of sites. The inset is a saturation plot using the same data as was used for the Scatchard analysis. Using the computer program LIGAND (29), we analyzed four experiments simultaneously. The analysis yielded an association constant (Ka) of 1.16 ± 0.26 (SEM) x 106 M-1 and a binding capacity of 22 pmol/mg of membrane protein.
To determine the ligand specificity of the receptor, the ability of radioinert CBG to compete with the specific binding of '25I-CBG to prostatic membranes was compared with that of TEBG and two other human plasma proteins, transferrin and albumin (Fig. 3) . None of these proteins significantly inhibited specific CBG binding to the membranes, attesting to the specificity of the CBG-membrane interaction.
Human and rhesus monkey (Macaca mulatta) CBGs are immunologically very similar (30) . Therefore, in order to study the tissue distribution of specific CBG binding, and in the absence of the ready availability of fresh human tissues, we examined CBG binding in membranes freshly prepared from the kidney, spleen, liver, and uterus of a rhesus monkey (Fig. 4) (1)]. Although the prostate is not considered to be a major target organ for cortisol or progesterone, its stroma, which constitutes about 50% of the gland, contains elements such as connective tissue, blood vessels, and smooth muscle which are well known to be responsive to glucocorticoids. Hence, these data are compatible with the hypothesis that CBG binding to membranes is involved with cortisol and progesterone action.
There is a previous report of a putative CBG receptor on human liver membranes (31) . The data in that report showed specific binding of 125I-labeled asialo-CBG to human hepatic membranes. However, native CBG was almost four orders of magnitude less effective than asialo-CBG itself in the displacement of 125I-labeled asialo-CBG (31) . Thus, the observed binding activity can be attributed most reasonably to the interaction of 125-labeled asialo-CBG with the well-known liver membrane asialoglycoprotein receptor (32) . Displacement of the 125I-labeled asialo-CBG could easily have been due to a trace (<0.1%) of asialo-CBG contaminating the purified CBG used as competitor.
We recently reported (21) that membranes from human prostate contain specific binding sites for another plasma steroid-binding protein, TEBG. It is important to be aware of the fact that the apparent dissociation constants (Kd) of the CBG and TEBG receptors [8.7 x 10-7 M and 1.5 x 10-8 M (21), respectively] are close to the average concentration of CBG and TEBG in male plasma. This relationship dictates that the density of CBG and TEBG on the surface of target cells (i.e., that which is receptor-bound), and hence their biological effects, would be altered by changes in either their plasma concentration or the concentration of their respective receptors. The system is clearly designed to be responsive to both steroid-binding protein and to receptor.
We have documented the existence of saturable and specific binding sites for CBG in membranes derived from the human prostate and from target organs for cortisol and progesterone from the rhesus monkey. We previously demonstrated receptors for TEBG in human prostatic membranes (21) . Taken together, our results on the CBG and TEBG receptors, along with the recently published report of a TEBG receptor in human decidual endometrium membrane (33) , raise the possibility that CBG and TEBG may serve to transport steroid hormones into target tissues via specific membrane receptors. Since it is generally accepted that the specificity of receptor-mediated endocytosis resides exclusively in the initial binding step between a ligand and its receptor (34) , this hypothesis both supports and is supported by previous reports indicating the intracellular presence of CBG in various cortisol and progresterone target cells (2, 6-15, 18, 20) ; the presence of CBG-like molecules on membranes from rat pituitary (17) and rat liver cells (16) ; the intracellular presence of TEBG in various androgen and estrogen target cells (35) (36) (37) (38) (39) ; and the observation that cortisol bound to CBG is physiologically active (5, 40) . However, direct evidence for the above hypothesis is not yet at hand, and it is possible that the binding of CBG to its receptor may subserve an as yet unknown function that is unrelated to the transport of steroids into target cells.
Finally, the classic, two-step model of steroid hormone action has been questioned. The classic model posits a cytosolic receptor for the steroid, whose association constant ensures that there is essentially no unbound steroid in the cell cytoplasm. Thus, in addition to transporting the steroid into the nucleus, the receptor creates a steep concentration gradient down which the plasma free hormone can flow into the cytoplasm by simple diffusion (4) . Recent evidence indicates that, at least for progesterone (41, 42) and estrogens (43) (44) (45) (46) , the cytosolic receptor may be an artifact of cell disruption and that all of the receptor is nuclear. Therefore, we might be left without a mechanism to create a large positive steroid concentration gradient between the cell cytoplasm and the plasma. Obviously, such a gradient is not a necessary condition for steroid hormone action. The effects of steroid hormones could still proceed by the passive diffusion of steroids through the plasma and nuclear membranes and into the nucleus. However, concurrent with a small, steady diffusion of free steroid hormones into cells, steroids could be augmented in target cells, as needed, by the internalization of bound steroids via membrane receptors for CBG and TEBG. Thus, the active transport of steroid hormones into target cells by CBG and TEBG by way of specific receptors would lend an additional degree of specificity and control to steroid hormone action.
